Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$17.3M Sell
719,586
-29,372
-4% -$768K 0.09% 134
2026
Q1
$21M Buy
748,958
+44,096
+6% +$1.17M 0.12% 97
2025
Q4
$17.6M Sell
704,862
-88,665
-11% -$2.24M 0.14% 114
2025
Q3
$20.2M Buy
793,527
+2,600
+0.3% +$64.2K 0.15% 94
2025
Q2
$19.2M Buy
790,927
+202,251
+34% +$4.72M 0.12% 97
2025
Q1
$14.9M Buy
588,676
+63,359
+12% +$1.66M 0.07% 112
2024
Q4
$13.9M Sell
525,317
-21,204
-4% -$575K 0.07% 124
2024
Q3
$15.8M Buy
546,521
+77,493
+17% +$2.26M 0.08% 112
2024
Q2
$13.1M Buy
469,028
+32,877
+8% +$905K 0.09% 132
2024
Q1
$12.1M Buy
436,151
+104,603
+32% +$2.9M 0.09% 135
2023
Q4
$9.55M Sell
331,548
-164,538
-33% -$4.97M 0.1% 125
2023
Q3
$16.5M Sell
496,086
-6,429
-1% -$227K 0.18% 64
2023
Q2
$18.4M Sell
502,515
-2,541
-0.5% -$98.9K 0.22% 63
2023
Q1
$20.6M Sell
505,056
-7,171
-1% -$310K 0.24% 52
2022
Q4
$26.2M Buy
512,227
+158,972
+45% +$7.62M 0.33% 42
2022
Q3
$15.5M Buy
353,255
+50,969
+17% +$2.48M 0.24% 51
2022
Q2
$15.8M Buy
302,286
+8,090
+3% +$412K 0.29% 51
2022
Q1
$15.2M Buy
294,196
+138,964
+90% +$7.21M 0.22% 58
2021
Q4
$9.17M Sell
155,232
-14,102
-8% -$699K 0.13% 75
2021
Q3
$7.28M Sell
169,334
-196,437
-54% -$8.7M 0.1% 83
2021
Q2
$14.3M Sell
365,771
-874,510
-71% -$34M 0.13% 122
2021
Q1
$44.9M Sell
1,240,281
-1,151,170
-48% -$40.9M 0.31% 95
2020
Q4
$88M Sell
2,391,451
-1,267,892
-35% -$46.5M 0.47% 47
2020
Q3
$127M Sell
3,659,343
-825,471
-18% -$28.9M 0.63% 31
2020
Q2
$139M Sell
4,484,814
-1,414,860
-24% -$48.1M 0.67% 27
2020
Q1
$183M Sell
5,899,674
-174,192
-3% -$5.94M 0.97% 18
2019
Q4
$226M Sell
6,073,866
-2,116,936
-26% -$75.4M 0.95% 24
2019
Q3
$279M Buy
8,190,802
+60,141
+0.7% +$2.19M 0.82% 30
2019
Q2
$334M Buy
8,130,661
+627,858
+8% +$24.9M 1.02% 20
2019
Q1
$302M Buy
7,502,803
+252,239
+3% +$10.1M 1.09% 22
2018
Q4
$300M Sell
7,250,564
-814,215
-10% -$33.8M 1.21% 18
2018
Q3
$337M Sell
8,064,779
-1,847,148
-19% -$71.1M 1.09% 18
2018
Q2
$341M Sell
9,911,927
-72,256
-0.7% -$2.47M 1.07% 18
2018
Q1
$336M Buy
9,984,183
+589,122
+6% +$20.3M 1.05% 17
2017
Q4
$323M Sell
9,395,061
-270,648
-3% -$9.23M 0.98% 15
2017
Q3
$327M Sell
9,665,709
-256,556
-3% -$8.25M 1.03% 15
2017
Q2
$316M Sell
9,922,265
-170,974
-2% -$5.39M 1.04% 14
2017
Q1
$328M Sell
10,093,239
-516
-0% -$16.3K 1.1% 14
2016
Q4
$311M Buy
10,093,755
+1,776,045
+21% +$54.2M 1.09% 16
2016
Q3
$267M Buy
8,317,710
+209,783
+3% +$7.01M 1.01% 21
2016
Q2
$271M Sell
8,107,927
-332,556
-4% -$10.6M 1.06% 18
2016
Q1
$237M Buy
8,440,483
+203,068
+2% +$5.8M 0.96% 20
2015
Q4
$252M Buy
8,237,415
+178,089
+2% +$5.6M 1.02% 17
2015
Q3
$240M Buy
8,059,326
+760,181
+10% +$24.4M 1.03% 20
2015
Q2
$232M Buy
7,299,145
+1,800,561
+33% +$58.7M 0.89% 25
2015
Q1
$181M Sell
5,498,584
-330,901
-6% -$10.5M 0.8% 25
2014
Q4
$172M Sell
5,829,485
-358,094
-6% -$10.3M 0.73% 30
2014
Q3
$174M Buy
6,187,579
+231,645
+4% +$6.5M 0.72% 31
2014
Q2
$168M Buy
5,955,934
+898,186
+18% +$25.6M 0.7% 36
2014
Q1
$154M Sell
5,057,748
-759,493
-13% -$22.6M 0.69% 36
2013
Q4
$169M Buy
5,817,241
+222,696
+4% +$6.48M 0.72% 37
2013
Q3
$152M Sell
5,594,545
-2,628,348
-32% -$71.5M 0.78% 30
2013
Q2
$219M Buy
+8,222,893
New +$227M 1.18% 17

Other funds holding PFE

Prudential plc's PFE Position: Q2 2026 in Review

Prudential plc reduced its Pfizer (PFE) stake by 3.9% in Q2 2026, selling an estimated $768K and leaving 719,586 shares worth $17.3M. The position accounts for 0.09% of the portfolio, ranked #134.

Prudential plc first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $341M in Q2 2018. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Prudential plc held 719,586 shares of Pfizer worth $17.3M as of Q2 2026.
  • Prudential plc sold 29,372 Pfizer shares in Q2 2026, an estimated $768K.
  • Pfizer made up 0.09% of Prudential plc's portfolio in Q2 2026, its #134 holding.
  • Prudential plc first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
  • Prudential plc's Pfizer position peaked at $341M in Q2 2018.
  • 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Prudential plc's 13F filing for Q2 2026, filed 14 Aug 2026.